Meet the new editor of FierceDrugDelivery

Hi! I'm Damian Garde, and I'm your new editor of FierceDrugDelivery. If you're reading this, you obviously understand the importance of drug delivery in the biotech universe, so I won't bore you with a spiel about that. However, I will say this: You can count on FierceDrugDelivery to be there as researchers wrap their heads around nanotechnology's possibilities, as developers reformulate to improve solubility, as devicemakers market new means of delivering therapeutic molecules, and as this fast-paced and fascinating field continues to grow. If you have any tips, pitches or feedback, don't hesitate to contact me via email. -- Damian (Twitter)

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.